Business Description
Medigene AG
ISIN : DE000A1X3W00
Description
Financial Strength
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 4.88 | |||||
Equity-to-Asset | 0.72 | |||||
Debt-to-Equity | 0.11 | |||||
Debt-to-EBITDA | -0.38 | |||||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | -9.63 | |||||
Beneish M-Score | -2.79 | |||||
WACC vs ROIC |
Growth Rank
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 43.2 | |||||
3-Year EPS without NRI Growth Rate | 25.1 | |||||
3-Year Book Growth Rate | -23.2 |
Momentum Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 51.6 | |||||
9-Day RSI | 57.46 | |||||
14-Day RSI | 59.15 | |||||
6-1 Month Momentum % | -18.08 | |||||
12-1 Month Momentum % | -24.08 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 4.74 | |||||
Quick Ratio | 4.74 | |||||
Cash Ratio | 2.81 | |||||
Days Sales Outstanding | 76.15 | |||||
Days Payable | 128.77 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Shareholder Yield % | 0.34 |
Profitability Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 76.85 | |||||
Operating Margin % | -340.78 | |||||
Net Margin % | -323.69 | |||||
FCF Margin % | -161.54 | |||||
ROE % | -69.37 | |||||
ROA % | -51.46 | |||||
ROIC % | -92.66 | |||||
ROC (Joel Greenblatt) % | -350 | |||||
ROCE % | -61.35 |
GF Value Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Price-to-Owner-Earnings | 4.89 | |||||
PS Ratio | 6.36 | |||||
PB Ratio | 1.9 | |||||
Price-to-Tangible-Book | 2.57 | |||||
EV-to-EBIT | -1.51 | |||||
EV-to-Forward-EBIT | -2.05 | |||||
EV-to-EBITDA | -5.19 | |||||
EV-to-Forward-EBITDA | -2.05 | |||||
EV-to-Revenue | 5.14 | |||||
EV-to-Forward-Revenue | 1.91 | |||||
EV-to-FCF | -3.06 | |||||
Price-to-Median-PS-Value | 0.15 | |||||
Price-to-Net-Current-Asset-Value | 3.25 | |||||
Price-to-Net-Cash | 11.11 | |||||
Earnings Yield (Greenblatt) % | -66.39 | |||||
FCF Yield % | -24.41 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Medigene AG Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | 9.027 | ||
EPS (TTM) (€) | -1.19 | ||
Beta | 1.08 | ||
Volatility % | 25.04 | ||
14-Day RSI | 59.15 | ||
14-Day ATR (€) | 0.245006 | ||
20-Day SMA (€) | 1.7705 | ||
12-1 Month Momentum % | -24.08 | ||
52-Week Range (€) | 1.35 - 2.9 | ||
Shares Outstanding (Mil) | 24.56 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 6 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Medigene AG Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Medigene AG Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
Medigene AG Frequently Asked Questions
What is Medigene AG(XTER:MDG1)'s stock price today?
When is next earnings date of Medigene AG(XTER:MDG1)?
Does Medigene AG(XTER:MDG1) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |